1. Recent Findings of the Comparative Efficacy and Tolerability of Antidepressants for Major Depressive Disorder: Do We Now Know What to Prescribe?

   • Matthew V. Rudorfer

   Editorial 06 September 2018 Pages: 807 - 811

2. Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis

   • Rosa C. Lucchetta
   • Fernanda S. Tonin
   • Astrid Wiens

   Systematic Review 16 July 2018 Pages: 813 - 826

   

3. Therapeutic Management of the Overlapping Syndromes of Atypical Parkinsonism

   • Nikolaos Giagkou
   • Maria Stamelou

   Review Article 27 July 2018 Pages: 827 - 837

4. Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research

   • Yvonne Höller
   • Christoph Helmstaedter
   • Klaus Lehnertz

   Review Article Open access 27 August 2018 Pages: 839 - 848

5. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

   • John A. Hey
   • Petr Kocis
   • Martin Tolar

   Original Research Article Open access 03 August 2018 Pages: 849 - 861

   

6. Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey

   • Natalie Bareis
   • Trisha A. Sando
   • Steven A. Cohen

   Original Research Article 16 July 2018 Pages: 863 - 871

   

7. Correction to: Propofol: A Review of its Role in Pediatric Anesthesia and Sedation

   • Vidya Chidambaran
   • Andrew Costandi
   • Ajay D’Mello

   Correction 13 August 2018 Pages: 873 - 873

8. Buprenorphine/Naloxone (Zubsolv^®): A Review in Opioid Dependence

   • Young-A Heo
   • Lesley J. Scott

   Adis Drug Evaluation 16 August 2018 Pages: 875 - 882

9. Ocrelizumab: A Review in Multiple Sclerosis

   • Yahiya Y. Syed

   Adis Drug Evaluation 31 August 2018 Pages: 883 - 890